Nv5 Global (NVEE) Share Value Rose While Grandeur Peak Global Advisors Cut Its Stake; As Johnson & Johnson (JNJ) Market Value Declined, Shareholder Midas Management Trimmed Position

Johnson & Johnson (NYSE:JNJ) Logo

Midas Management Corp decreased its stake in Johnson & Johnson (JNJ) by 33.68% based on its latest 2018Q4 regulatory filing with the SEC. Midas Management Corp sold 3,200 shares as the company’s stock declined 5.44% while stock markets rallied. The institutional investor held 6,300 shares of the major pharmaceuticals company at the end of 2018Q4, valued at $813,000, down from 9,500 at the end of the previous reported quarter. Midas Management Corp who had been investing in Johnson & Johnson for a number of months, seems to be less bullish one the $366.40B market cap company. The stock decreased 0.30% or $0.42 during the last trading session, reaching $137.6. About 11.92 million shares traded or 36.66% up from the average. Johnson & Johnson (NYSE:JNJ) has risen 8.80% since March 17, 2018 and is uptrending. It has outperformed by 4.43% the S&P500. Some Historical JNJ News: 24/04/2018 – J&J Bond Trading 2x Average; Clients Net Buyers; 29/05/2018 – Johnson & Johnson to Participate in the Goldman Sachs 39th Annual Global Healthcare Conference; 17/04/2018 – J&J – FIRST-QUARTER 2018 NET EARNINGS INCLUDED AFTER-TAX INTANGIBLE AMORTIZATION EXPENSE OF APPROXIMATELY $1.0 BLN; 16/04/2018 – BRISTOL-MYERS SQUIBB SAYS JANSSEN WILL PAY CO UPFRONT SUM ALONG WITH POTENTIAL DEVELOPMENT & REGULATORY MILESTONE PAYMENTS; 25/04/2018 – J&J GETS COURT TO THROW OUT $151 MILLION DEPUY HIP VERDICT; 29/05/2018 – #3 Genmab takes a hit after J&J sounds retreat on cancer combos, as patient deaths force researches to scrap trials; 16/04/2018 – BRISTOL-MYERS SQUIBB ANNOUNCES WORLDWIDE COLLABORATION WITH JANSSEN TO DEVELOP & COMMERCIALIZE BRISTOL-MYERS’ FACTOR XIA INHIBITOR, BMS-986177; 27/03/2018 – FDA: Johnson & Johnson Vision Care, Inc.- ACUVUE OASYS Brand Contact Lenses with HYDRACLEAR PLUS; 30/04/2018 – Football Rumors: Steelers Release S J.J. Wilcox; 19/03/2018 – AstraZeneca Presents New Data Evaluating Safety and Efficacy of FARXIGA in Patients with Type 2 Diabetes and Moderate Renal

Grandeur Peak Global Advisors Llc decreased its stake in Nv5 Global Inc (NVEE) by 14.48% based on its latest 2018Q4 regulatory filing with the SEC. Grandeur Peak Global Advisors Llc sold 8,525 shares as the company’s stock rose 9.01% with the market. The institutional investor held 50,350 shares of the consumer services company at the end of 2018Q4, valued at $3.05M, down from 58,875 at the end of the previous reported quarter. Grandeur Peak Global Advisors Llc who had been investing in Nv5 Global Inc for a number of months, seems to be less bullish one the $765.60 million market cap company. The stock increased 4.85% or $2.82 during the last trading session, reaching $61. About 168,229 shares traded or 40.35% up from the average. NV5 Global, Inc. (NASDAQ:NVEE) has risen 72.79% since March 17, 2018 and is uptrending. It has outperformed by 68.42% the S&P500. Some Historical NVEE News: 21/04/2018 – DJ NV5 Global Inc, Inst Holders, 1Q 2018 (NVEE); 08/03/2018 – NV5 Global 4Q Rev $94M; 08/03/2018 – NV5 Global 4Q EPS $1.06; 08/03/2018 – NV5 Global Sees 2018 Adj EPS $2.92-Adj EPS $3.21; 03/05/2018 – NV5 GLOBAL INC – BACKLOG WAS $309 MLN AS OF MARCH 31, 2018 COMPARED TO $225 MLN AS OF APRIL 1, 2017; 09/04/2018 – NV5 Forms Golden Cross: Technicals; 03/05/2018 – NV5 GLOBAL INC – EXPECTS GROSS REVENUES WILL RANGE FROM $380 MLN TO $415 MLN FOR 2018; 03/05/2018 – NV5 GLOBAL INC NVEE.O SEES FY 2018 GAAP SHR $2.26 TO $2.54; 03/05/2018 – NV5 GLOBAL INC NVEE.O SEES FY 2018 ADJUSTED SHR $3.00 TO $3.30; 08/03/2018 – NV5 Global Sees 2018 Rev $370M-$405M

More notable recent NV5 Global, Inc. (NASDAQ:NVEE) news were published by: Nasdaq.com which released: “Mid-Afternoon Market Update: NV5 Global Drops After Q4 Results; Seelos Therapeutics Shares Climb – Nasdaq” on March 08, 2019, also Globenewswire.com with their article: “NV5 Appoints Ivor Jarman Executive Vice President of International Operations – GlobeNewswire” published on December 03, 2018, Nasdaq.com published: “Mid-Day Market Update: Crude Oil Down 3%; Stellar Biotechnologies Shares Surge – Nasdaq” on March 08, 2019. More interesting news about NV5 Global, Inc. (NASDAQ:NVEE) were released by: Globenewswire.com and their article: “NV5 Awarded $25 Million in New Natural Gas Contracts – GlobeNewswire” published on November 01, 2018 as well as Seekingalpha.com‘s news article titled: “NV5 announces acquisition of CHI Engineering Services, Inc. – Seeking Alpha” with publication date: November 05, 2018.

Grandeur Peak Global Advisors Llc, which manages about $1.61 billion and $779.28 million US Long portfolio, upped its stake in Huya Inc by 32,750 shares to 85,640 shares, valued at $1.33 million in 2018Q4, according to the filing. It also increased its holding in Wns Holdings Ltd (NYSE:WNS) by 174,938 shares in the quarter, for a total of 1.05 million shares, and has risen its stake in Oxford Immunotec Global Plc (NASDAQ:OXFD).

Since October 3, 2018, it had 1 insider buy, and 4 sales for $2.62 million activity. WRIGHT DICKERSON also sold $831,435 worth of NV5 Global, Inc. (NASDAQ:NVEE) on Wednesday, October 3. 7,000 shares valued at $452,126 were sold by ALFORD DONALD C on Wednesday, December 12. Pruitt William D bought $120,570 worth of stock or 2,000 shares.

Investors sentiment decreased to 0.92 in 2018 Q4. Its down 0.77, from 1.69 in 2018Q3. It worsened, as 17 investors sold NVEE shares while 48 reduced holdings. 24 funds opened positions while 36 raised stakes. 7.54 million shares or 3.58% more from 7.28 million shares in 2018Q3 were reported. Toronto Dominion Savings Bank invested 0% of its portfolio in NV5 Global, Inc. (NASDAQ:NVEE). State Board Of Administration Of Florida Retirement Systems owns 4,946 shares or 0% of their US portfolio. Legal General Group Pcl stated it has 0% in NV5 Global, Inc. (NASDAQ:NVEE). Geode Llc has invested 0% in NV5 Global, Inc. (NASDAQ:NVEE). Pittenger And Anderson invested in 15 shares or 0% of the stock. Renaissance Ltd Liability holds 7,957 shares or 0.02% of its portfolio. Robeco Institutional Asset Bv invested 0% of its portfolio in NV5 Global, Inc. (NASDAQ:NVEE). 11,198 are held by Campbell Newman Asset Management. State Street, a Massachusetts-based fund reported 165,946 shares. Renaissance Techs Ltd Liability Corp has 29,254 shares for 0% of their portfolio. Barclays Plc stated it has 0% in NV5 Global, Inc. (NASDAQ:NVEE). Deutsche Bank Ag owns 44,338 shares for 0% of their portfolio. Driehaus Capital Mgmt Ltd Liability Corporation reported 154,474 shares. Woodstock Corp invested 0.61% of its portfolio in NV5 Global, Inc. (NASDAQ:NVEE). California State Teachers Retirement Sys has invested 0% in NV5 Global, Inc. (NASDAQ:NVEE).

Analysts await Johnson & Johnson (NYSE:JNJ) to report earnings on April, 16. They expect $2.10 EPS, up 1.94% or $0.04 from last year’s $2.06 per share. JNJ’s profit will be $5.59B for 16.38 P/E if the $2.10 EPS becomes a reality. After $1.97 actual EPS reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts 6.60% EPS growth.

Since November 7, 2018, it had 3 insider buys, and 6 selling transactions for $74.45 million activity. Shares for $536,638 were sold by Kapusta Ronald A. PRINCE CHARLES had bought 2,000 shares worth $268,731 on Friday, December 14. Gorsky Alex sold $38.60M worth of stock or 264,465 shares. $4.41 million worth of stock was sold by Sneed Michael E on Friday, November 23. On Monday, December 3 Fasolo Peter sold $24.41M worth of Johnson & Johnson (NYSE:JNJ) or 166,695 shares. On Friday, December 14 the insider PEREZ WILLIAM D bought $133,910.

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Seekingalpha.com which released: “J&J eyes Missouri Supreme Court ruling – Seeking Alpha” on February 25, 2019, also Seekingalpha.com with their article: “Johnson & Johnson Looks Undervalued: Time To Buy? – Seeking Alpha” published on February 19, 2019, Bizjournals.com published: “See inside Johnson & Johnson’s new $18M Lake Nona facility (PHOTOS) – Orlando Business Journal” on March 05, 2019. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: 247Wallst.com and their article: “How Much More Talc Fallout Will Johnson & Johnson Face After This $29 Million Verdict? – 24/7 Wall St.” published on March 14, 2019 as well as Seekingalpha.com‘s news article titled: “Novartis sues J&J over “misleading” Tremfya data – Seeking Alpha” with publication date: March 04, 2019.

Midas Management Corp, which manages about $51.15 million and $208.56 million US Long portfolio, upped its stake in Hawaiian Holdings Inc. (NASDAQ:HA) by 20,500 shares to 90,000 shares, valued at $2.38M in 2018Q4, according to the filing. It also increased its holding in Wabco Holdings Inc. (NYSE:WBC) by 8,900 shares in the quarter, for a total of 21,900 shares, and has risen its stake in Prudential Financial Inc. (NYSE:PRU).

NV5 Global, Inc. (NASDAQ:NVEE) Institutional Positions Chart